Table 2.
Metabolic and cardiovascular risk parameters in control women and in women with PCOS
| PCOS | Control | ||
|---|---|---|---|
| N = 24 | N = 12 | P-value | |
| Fasting blood glucose (mg/dl) | 86.29 ± 9.90 | 82.08 ± 5,12 | P = 0.17 |
| Fasting insulin (mUI/ml) | 22.0 ± 12.0 | 7.65 ± 5.48 | P = <0.001a |
| HOMAIR | 4.54 ± 2.77 | 1.82 ± 1.17 | P = <0.05a |
| Total cholesterol (mg/ml) | 183.4 ± 30.35 | 168.6 ± 29.30 | P = 0.17 |
| HDL cholesterol (mg/ml) | 51 ± 8,67 | 59,16 ± 9,19 | P = <0.05 a |
| PAI-1 (ng/ml) | 37,80 ± 20,98 | 17.2 ± 18.2 | P = 0.007a |
| F von Willebrand (%) | 86,86 ± 34,25 | 103,65 ± 27,75 | P = 0.15 |
| Adiponectin | 6,05 ± 3,84 | 24 ± 4,26 | P = 0.000a |
Values are mean ± SD;
a P < 0.001 (Student's t test) PCOS vs control group.